Prolymphocytic Leukemia: Clinical Trials

6 trials for Prolymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 unknown, 1 withdrawn. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 2, Terminated 2, Unknown 1, Withdrawn 1

Follow Prolymphocytic Leukemia: new trials by email Literature Review of Prolymphocytic Leukemia trials Research Report on Prolymphocytic Leukemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Fludarabine, Cyclophosphamide, Total Body Irradiation - Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL)
Not applicableTerminatedMasonic Cancer Center, University of Minnesota2002016-12-012026-05-20
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19
anti-CD19-CAR vector-transduced T cells - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableUnknownChinese PLA General Hospital122013-04-012016-01-28
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableWithdrawnRoswell Park Cancer Institute2012-05-012012-07-09
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
massage therapy, questionnaire administration, quality-of-life assessment - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedWake Forest University Health Sciences802010-04-012018-07-02
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
arsenic trioxide, laboratory biomarker analysis - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma
Not applicableTerminatedNational Cancer Institute (NCI)252001-01-012013-02-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedFred Hutchinson Cancer Center51999-11-012017-05-24

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (6)  ·  Leukemia, Prolymphocytic (6)  ·  Lymphoma, Follicular (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Burkitt Lymphoma (4)  ·  Lymphoma, B-Cell, Marginal Zone (4)  ·  Lymphoma, Mantle-Cell (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Primary Myelofibrosis (4)  ·  Blast Crisis (3)  ·  Leukemia, Myeloid, Accelerated Phase (3)  ·  Leukemia, Myeloid, Chronic-Phase (3)  ·  Leukemia, Myelomonocytic, Chronic (3)  ·  Leukemia, Neutrophilic, Chronic (3)

Broader conditions

Chronic Disease (6)  ·  Disease Attributes (6)  ·  Hematologic Diseases (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Leukemia, B-Cell (6)  ·  Leukemia, Lymphoid (6)  ·  Lymphatic Diseases (6)  ·  Lymphoma, B-Cell (6)  ·  Lymphoproliferative Disorders (6)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)

Interventions

Cyclosporine (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine phosphate (2)  ·  Arsenic Trioxide (1)  ·  Cyclophosphamide (1)  ·  Massage (1)  ·  Mycophenolic Acid (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Therapeutics (1)  ·  fludarabine (1)

Sponsors

Chinese PLA General Hospital (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (4)  ·  China (1)

Top investigators

Ann Woolfrey (1)  ·  Claudio Brunstein, MD (1)  ·  Janet Tooze, PhD (1)  ·  Luis Isola (1)  ·  Philip McCarthy (1)

Results publications

PMID 18698002, PMID 26451310, PMID 29599530

NIH funding

P01CA018029 (1), P30CA015704 (1), R01CA085748 (1)